![Linda Burkly](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: 202 076 $ in data 30/06/2026
Linda C.
Burkly is Chief Scientific Officer & Executive VP at Editas Medicine, Inc. since 2023.
Formerly, Dr. Burkly was Vice President & Senior Distinguished Investigator at Biogen, Inc. from 2014 to 2022.
Education includes an undergraduate degree from Fairfield University and a doctorate from Tufts University.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 28/07/2026 | 62.369 ( 0,04% ) | 202 076 $ | 30/06/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| EDITAS MEDICINE, INC. | Direttore Tecnico/Scientifico/R&S | 24/07/2023 |
| Società | Posizione | Fine |
|---|---|---|
| BIOGEN INC. | Corporate Officer/Principal | 01/01/2022 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 4 |
|---|---|
Biogen, Inc.
 Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Fairfield University
 Fairfield University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tufts University
 Tufts University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Editas Medicine, Inc.
 Editas Medicine, Inc. BiotechnologyHealth Technology Manufactures gene editing medicines | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
